Summary.-Hypothyroidism, alone or combined with progesterone, significantly decreased 7,12-dimethylbenz(a)anthracene (DMBA) mammary tumorigenesis relative to controls. However, the decrease was less in the progesterone-treated group, and statistical analysis showed that progesterone enhanced tumorigenesis to the same extent in hypothyroid animals as in the controls. Most tumours in hypothyroid progesterone-treated rats were adenocarcinomata; in the absence of the hormone most tumours were benign. However, the difference between the tumour types in the 2 groups was not statistically significant.
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The morphological changes observed in the endocrine glands, genital tracts and non-neoplastic mammary tissue, considered in relation to previously reported data, suggest that hypothyroidism reduced the tumour yield mainly by secondarily inhibiting somatotrophin production and secretion, although the effect of decreased food intake could not be excluded completely. The higher tumour yield in the hypothyroid progesterone-treated rats may have been due to higher circulating levels of prolactin in this group compared with those in the hypothyroid group which received no hormone.
INDUCTION of mammary tumours by
7,12-dimethylbenz(a)anthracene (DMBA) is influenced markedly by the hormonal environment of the animal. Progesterone, while not carcinogenic per se, significantly enhances DMBA mammary tumorigenesis in entire rats when hormone injections are begun just before or after carcinogen administration (Jabara, 1967; Jabara and Harcourt, 1970) . By contrast, ovariectomy performed 7 days before feeding DMBA totally inhibits mammary tumour development (Jabara and Harcourt, 1970 ) whereas adrenalectomy has no significant effect on tumorigenesis (Jabara and Harcourt, 1971) . Reported effects of hypothyroidism on mammary tumour induction range from an enhancement of carcinogenesis Thomas, 1966, 1967; Davidson, Owen and Thomas, 1969) to a reduction (Helfenstein, Young and Currie, 1962; Cameron, Owen and Thomas, 1970; Kellen, 1972) ; Gruenstein et al. (1968) found hypothyroidism to be without apparent effect on tumour development. In these reports only tumour incidences and, in some papers, tumour induction times were investigated. As each endocrine gland is part of a functionally related system, histological study of other endocrine glands might help to explain the observed effects of hypothyroidism on DMBA mammary carcinogenesis.
The present experiments were undertaken to determine the effects of hypothy- (Jabara and Harcourt, 1970 Beginning 4 weeks after DMBA administration, all rats were palpated weekly and any mammary tumours recorded, measured and graphed as described previously (Jabara, 1967) .
Treatment and examination of tissues.-At autopsy a segment of proximal trachea in the region normally occupied by the thyroid gland was removed, as well as the ovaries, uterus, vagina, adrenals, pituitary gland, mammary tissue and portions of each mammary tumour. Tissues were fixed in 1000 buffered formalin and 5 ,um paraffin sections were cut from all tissues except the trachea and pituitary gland. Each segment of trachea was serially sectioned, and 2-5-4 ,um sections were cut from each pituitary gland in the median transverse plane. All tissue sections other than pituitary gland were stained with haematoxylin and eosin. Pituitary gland sections were stained by Gomori's (1950) aldehyde-fuchsin counter-stained with Crossmon's (1937) In the statistical analysis of the results, " tumour incidence" was interpreted as the proportion of rats having developed at least one tumour at a time T. This is the same as the proportion of rats with a latent period <T, and thus an analysis of latent period only was considered adequate as an indicator of differences in tumour incidence. Part of the analysis was based on an exponential model for the distribution of latent periods (Armitage and Zippin, 1966) . In this case a change in mean latent period implies a change in tumour incidence and vice versa. One difficulty in analysing the data on latent periods was the " censoring " of observations; some rats died before tumours became evident whereas in others tumours were detected only at autopsy. Thus there were lower and upper limits, respectively, to the actual latent period. The latent period data were analysed (1) by adapting the procedure of Armitage and Zippin (1966) which uses a parametric approach and the likelihood ratio technique on the assumption of exponentiallydistributed latent periods, and (2) by Gehan's (1965) 
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Evidence of hypothyroidism A pilot study showed that 1 mCi of 1311 given to 30-day old rats produced marked thyroid atrophy within [14] [15] [16] [17] [18] [19] [20] days; hence rats in Group 1 and 2 should have been hypothyroid when DMBA was administered at 50 days of age (20 days after 131J administration), an assumption borne out by the following findings: (1) Serial sections of the proximal trachea at the termination of the experiment showed that the thyroid gland was markedly atrophic in every rat of Group 1 and 2, although the extent of atrophy varied. In most rats both lobes were either completely or partially fibrosed, the fibrous tissue sometimes showing hyaline degeneration and frequently calcification with an accompanying foreign body inflammatory reaction ( Fig. 1-3 ). Where fibrosis was incomplete, very small follicles remained whose lumina were generally empty ( Fig.  2 and 4) . Likewise, the isthmus in all animals was atrophic and was composed of very small follicles, frequently devoid of colloid (Fig. 1) . In all rats the parathyroids either appeared normal or showed slight atrophy and minimal fibrosis (Fig.  4) . (2) Large numbers of thyroidectomy cells were present in the anterior pituitary glands from rats in both groups (1 and 2) (see below). (3) Each animal in Group I and 2 had a dry, scaly skin bearing sparse brittle hair. (4) There was marked stunting of body growth. The mean body wveights of the rats at the conclusion of the experiment were 182 and 204 g in Group I and 2 respectively, compared with the control means of 273 and 306 g in Group 3 and 4 respectively.
Tumour incidence and latent period
The findings are shown in Table I . Both methods of statistical analysis of these data gave substantially similar results, and the P values reported below are those obtained by Gehan's (1965) method.
Mammarv tumours arose in both groups of hypothyroid rats. Comparison of the latent periods (tumour incidences) in Group 1 and 3 showed that hypothyroidism caused a significant lengthening of tumour induction time (P < 0.02). Similarly, the average latent period in Group 2, while not significantly different from that in Group 1 or 3, was significantly longer than that in Group 4 (P < 0.001).
A 2 x 2 factorial analysis revealed that, while the main effect of 1311 was significant (P < 0 001) and the main effect of progesterone was significant (P < 0 05), there was no significant interaction between 131 and progesterone in relation to the latent period in all 4 groups of rats (P approximated 0.30).
Active tumour centres
Hypothyroidism significantly reduced the average number of active tumour centres per rat in Group I and 2 relative to Group 3, wlhether or not progesterone was also administered (P < 0 005 and P < 0 01 respectively) ( Table I) . Although the reduction was less marked FIC'. 1. Photomicrograph of a TS of thyroid gland and trachea from a rat in Group 2 (DAMBA + P+ 15 + 13lj) showing complete fibrosis of one lobe and almost complete fibrosis of the other except for a small group of tiny, empty follicles (arrowed) (ref. in Group 2 than in Group 1, the difference was not significant.
Tumour growth behaviour Three main types of tumour growth behaviour (Jabara, 1967) occurred in both groups of hypothyroid animals (Table I ). Only 9 tumours in Group 1 and 20 tumours in Group 2 could be followed long enough to assess their growth behaviour. In Group 1, similar numbers of tumours showed either continuous growth or partial regression, while in Group 2 more than half the neoplasms remained static after an initial short growth period during which, with the exception of one tumour, they became palpable but did not reach a measurable size (1 cm or more in longest diameter) (Table I ). However, differences between the numbers of classifiable neoplasms exhibiting the 3 main types of tumour growth in the 2 hypothyroid groups were not statistically significant, indicating that the presence of progesterone (Group 2) did not modify tumour growth behaviour.
No direct correlation was apparent between growth behaviour and histological tumour type in Group 1 and 2, or between growth behaviour and microscopic structure within a particular neoplastic type.
Locations and types of tumnours
As has been observed previously in entire rats (Jabara and Harcourt, 1970) , in Group 1 and 2 neoplasms arose equally on both sides and most tumours were in the anterior 3 pairs of glands.
All 3 histological types of tumours (Jabara, 1967 ) occurred in Group 1 and 2. In Group 1 most tumours were benign (11/18), while in Group 2 the majority were malignant (15/24), most being adenocarcinomata (Table I) . However, the difference between the tumour types in the 2 groups was not statistically significant.
Ovaries, uteri and vaginae
Microscopic examination of the ovaries, uteri and vaginae from the hypothyroid rats in Group 1 revealed that all animals at death were either in dioestrus or were pseudopregnant (Long and Evans, 1922; V7elardo et al., 1953) . The latter diagnosis was supported by the presence of deciduomata (Velardo et al., 1953) in one or both uterine cornu in 47 % (7/15) of animals ( Fig. 5 and 6 ). Of these 7 rats, 4 bore 1 or more mammary neoplasms and 3 were tumour free. Hence, there was no apparent correlation between deciduoma formation and tumour development.
In Group 2, 72 % ( 13/18) of rats were in dioestrus, 170% (3/18) in pro-oestrus and 110% (2118) 
Adrenal glands
The adrenals derived from animals in Group 1 and 2 were histologically similar and appeared slightly atrophic compared with those from the control groups. However, the degree of adrenal cortical necrosis, haemorrhage and calcification (Fig. 7) was comparable in all 4 groups.
Anterior pituitary glands
In comparison with differential cell counts of anterior pituitary glands from 22 untreated entire rats (Table II and  III) , hypothyroidism in Group 1 significantly reduced the number of lactotrophs (P < 0 001) and somatotrophs (P <0001 ) and, further, both types of acidophils showed a marked loss of cytoplasmic granules. There were also significantly fewer gonadotrophs in Group 1 (P < 0.001), whileboth the thyrotrophs and chromophobes were increased significantly (P < 0-001 and <0-001 respectively) (Table II and III) ; the thyrotrophs were also markedly enlarged, vacuolated and pleomorphic, and corresponded to thyroidectomy cells Griesbach, 1951, 1957) . With the exception of the lactotrophs, similar significant alterations in differential cell counts were observed in Group 2 pituitary glands as were seen in those from Group 1 (Table III) . In Group 2, however, the lactotrophs were only insignificantly reduced compared with their numbers in pituitaries from the untreated controls, and just failed at the 5 % level to be significantly increased compared with the number in pituitary glands from rats in Group 1 (P = 0-054) (Table III) .
M3ammary ti&sgue (non-neoplastic)
A subjective histological assessment of non-neoplastic mammary lobular-alveolar development in the 4 groups of rats revealed that it was approximately comparable in both hypothyroid groups, although mammae in Group 2 contained slightly larger alveoli and more secretion than did those in Group 1 (Fig. 8) . Such development was much greater in these 2 groups than that seen in either of the control groups; in the 2 control groups glandular development was less obvious in the mammae derived from animals treated with onlv DMBA.
DISCUSSION
The observation that hypothvroidism decreased, but did not totally inhibit, DMBA tumorigenesis confirms the findings of Helfenstein et al. (1962 ), Cameron et al. (1970 and Kellen (1972) for DMBA tumorigenesis, and Jull and Huggins (1960) and Newman and Moon (1968) for mammary tumours induced by 3-methylcholanthrene (3MCA). Grice et al. (1966 Grice et al. ( , 1967 and Davidson et al. (1969) claimed that hypothyroidism increased the incid-12 ence of DMBA-induced mammarytumours. However, these reports are difficult to evaluate because the strain of rat used by Davidson and colleagues was not stated and Grice et al. (1966 Grice et al. ( , 1967 did not record the dose of 131J used or the time of its administration to Sprague-Dawley rats; the time at which hypothyroidism is induced in relation to the time of feeding DMBA has been shown to affect profoundly the resulting tumour incidence (Shellabarger, 1969) .
Continuous progesterone administration to hypothyroid rats increased DMBA tumorigenesis compared with hvpothyroidism alone, although the tumour yield was still significantly lower and the latent period significantly longer than in the control groups treated with DMBA, either alone or combined with progesterone (Jabara and Harcourt, 1970) . However, statistically the enhancing effect of progesterone on latent period (tumour incidence) in hypothyroid rats was equivalent to that previously observed in entire DMBAtreated animals (Jabara, 1967; Jabara and Harcourt, 1970) . Progesterone administration did not modify-tumour growth behaviour in hypothyroid rats; a similar finding was observed previously when progesterone was given to the controls (Jabara and Harcourt, 1970) .
More tumours induced by DMBA in the hvpothvroid rats of Group 1 were benign than in any of the other 3 groups, but this difference was not statistically significant. Kellen (1972) reported a similar shift towards a more benign histological pattern FIG. 5 Fc. fi Fia. 7 FI1XG. 8 in the tumours induced in his hypothyroid DMBA-treated rats.
The mechanism whereby the thyroid gland influences mammary tumorigenesis is not clear. Jull and Huggins (1960) and Kellen (1972) attributed the inhibitory effect of hypothyroidism to the consequent reduction in food intake which has been shown to decrease markedly DMBAinduced mammary tumour development in entire rats (Gruenstein et al., 1968 Cameron et al. (1970) result in a decreased tumour yield, but the work of Grice et al. ( 1967) and Cameron et al. (1970) showed that the effect of 131I in rats is primarily that of inducing hypothyroidism. Other work suggested that hypothyroidism only decreases tumour growth after induction (Newman and Moon, 1968; Shellabarger, 1969) , and restoration of a euthyroid state by small daily doses of thyroxine at the time the carcinogen is fed results in a tumour incidence similar to that in entire carcinogen-treated controls (Jull and Huggins, 1960) . However, neither thyroxine nor 1311 administration to DMBA-fed rats results in tumour development in the absence of the ovaries (Grice et al., 1966) and the work of Sterental et al. (1963) suggests that this may be due to lack of secretion of one or more anterior pituitary hormones. Histological examination of endocrine glands from hypothyroid rats in the present series supports this last suggestion since, although changes were observed in both the pituitary and adrenal glands, the adrenal alterations appeared irrelevant to mammary carcinogenesis as such changes were present in all 4 groups and are well recognized in rats following DMBA administration (Huggins and Morii, 1961; Cefis and Goodall, 1965) . Further, adrenalectomy has not been found to affect DMBA mammary tumorigenesis significantly (Jabara and Harcourt, 1971) .
Marked alterations in the numbers of several cell types were found in the pituitary glands from both groups of hypothyroid rats. From current evidence (Young, 1961; Sterental et al., 1963; Tal- walker, Meites and Mizuno, 1964; Meites, 1972; Muihlbock, 1972) , the observed pituitary changes pertinent to mammary carcinogenesis appeared to be those relating to somatotrophs and lactotrophs which produce growth hormone (STH) and prolactin (LTH) respectively. The retardation in body growth and the significant decrease in pituitary somatotroph numbers in both hypothyroid groups suggest that plasma STH levels were probably decreased markedly in these rats. In support of this suggestion, other investigators have demonstrated a reduction in pituitary STH content in primary hypothyroid rats (Schooley, Friedkin and Evans, 1966; Nicoll et al., 1969 ) apparently due to a marked decrease in STH synthesis, storage and release (Catt, 1970a; Wilkins, Vanderlaan and Mayer, 1971 primary hypothyroidism (Grosvenor, 1961; Nicoll et al., 1969 ) is due to an increased release of the hormone resulting in elevated plasma LTH levels (Foley et al., 1972) . The marked non-neoplastic mammary lobular-alveolar development and limited secretion observed in both groups of hypothyroid rats no doubt reflected this elevation in plasma LTH levels, since LTH stimulates both mammary growth and lactation (Averill, 1966; Sinha and Schmidt, 1969) . Similarly, the presence of deciduoma and metrial gland formation in almost 50 % of rats in Group 1 indicated that LTH was being secreted, as well as oestrogen and progesterone (Horikoshi and Wiest, 1971; Schwartz and McCormack, 1972) . Since pituitary gonadotroph numbers were significantly reduced in both hypothyroid groups, absence of deciduonia in all rats of Group 2 was probably due to an alteration in the critical oestrogen: progesterone ratio by administration of exogenous progesterone. While the hypothalamic content of prolactin-inhibiting factor (PIF) is significantly reduced in rats by progesterone (Rothchild, 1960; Sar and Meites, 1968) , it is unaffected by hypothyroidism alone (Chen and Meites, 1969) . Recent investigations suggest that LTH secretion is also regulated by hypothalamic thyrotrophin-releasing factor (TRF) in rat and man (Tashjian, Barowsky and Jensen, 1971; Foley et al., 1972) . In primary hypothyroidism the action of TRF on the pituitary is virtually unopposed (Catt, 1970b) . Continuous action of TRF on the pituitary also accounts for the significant increase in size and number of thyrotrophs (Catt, 1970b) , as was observed in both hypothyroid groups in the present series and by others (Purves and Griesbach, 1951; Rosa and D'Angelo, 1971) .
The increase in pituitary chromophobe numbers observed in Group 1 and 2, while confirming the findings of Stein and Lisle (1942) and Goluboff et al. (1970) , appeared irrelevant to mammary carcinogenesis, as Romanov (1967) showed that chromophobes can differentiate into either acidophils or basophils, depending on the functional state of the pituitary gland.
In conclusion, it is suggested that, while decreased food intake may play some part in the reduced incidence of tumours in hypothyroid rats, the chief mechanism whereby hypothyroidism decreased the tumour yield was by secondary inhibition of pituitary STH production and secretion. It is of interest that Young (1961) induced mammary cancer in 550% of hypophysectomized rats which were fed 3MCA and injected with only oestrogen, progesterone and STH. It is further suggested that the higher tumour yield in Group 2, which received progesterone in addition to DMBA, compared with that in Group I may have been due to higher circulating levels of LTH in the former group; the larger alveoli and more abundant secretion observed in non-neoplastic mammary tissue in Group 2 supports this suggestion. Further work is required to substantiate this hypothesis.
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